1. Home
  2. CTXR vs ZDAI Comparison

CTXR vs ZDAI Comparison

Compare CTXR & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • ZDAI
  • Stock Information
  • Founded
  • CTXR 2007
  • ZDAI 2022
  • Country
  • CTXR United States
  • ZDAI Hong Kong
  • Employees
  • CTXR N/A
  • ZDAI N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • CTXR Health Care
  • ZDAI Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • ZDAI Nasdaq
  • Market Cap
  • CTXR 21.6M
  • ZDAI 20.6M
  • IPO Year
  • CTXR N/A
  • ZDAI 2024
  • Fundamental
  • Price
  • CTXR $1.67
  • ZDAI $0.60
  • Analyst Decision
  • CTXR Strong Buy
  • ZDAI
  • Analyst Count
  • CTXR 3
  • ZDAI 0
  • Target Price
  • CTXR $53.00
  • ZDAI N/A
  • AVG Volume (30 Days)
  • CTXR 1.5M
  • ZDAI 61.0K
  • Earning Date
  • CTXR 08-11-2025
  • ZDAI 08-15-2025
  • Dividend Yield
  • CTXR N/A
  • ZDAI N/A
  • EPS Growth
  • CTXR N/A
  • ZDAI N/A
  • EPS
  • CTXR N/A
  • ZDAI N/A
  • Revenue
  • CTXR N/A
  • ZDAI $17,166,534.00
  • Revenue This Year
  • CTXR N/A
  • ZDAI N/A
  • Revenue Next Year
  • CTXR N/A
  • ZDAI N/A
  • P/E Ratio
  • CTXR N/A
  • ZDAI $19.01
  • Revenue Growth
  • CTXR N/A
  • ZDAI 56.11
  • 52 Week Low
  • CTXR $0.65
  • ZDAI $0.37
  • 52 Week High
  • CTXR $26.25
  • ZDAI $107.36
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 56.18
  • ZDAI N/A
  • Support Level
  • CTXR $1.40
  • ZDAI N/A
  • Resistance Level
  • CTXR $1.67
  • ZDAI N/A
  • Average True Range (ATR)
  • CTXR 0.18
  • ZDAI 0.00
  • MACD
  • CTXR -0.03
  • ZDAI 0.00
  • Stochastic Oscillator
  • CTXR 36.90
  • ZDAI 0.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: